ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PLSE Pulse Biosciences Inc

7.78
-0.62 (-7.38%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Pulse Biosciences Inc PLSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.62 -7.38% 7.78 20:00:00
Open Price Low Price High Price Close Price Prev Close
8.82 8.57 9.085 8.71 8.40
more quote information »

Recent News

Date Time Source Heading
3/28/202416:12BWPulse Biosciences Reports Business Updates and Fourth..
3/28/202416:10BWPulse Biosciences Announces Plans to Initiate a Rights..
3/14/202416:05BWPulse Biosciences Schedules Fourth Quarter & Full Year 2023..
3/11/202409:10EDGAR2Form 8-K - Current report
3/08/202413:17BWPulse Biosciences Announces FDA 510(k) Clearance for its..
2/14/202409:22EDGAR2Form 8-K - Current report
2/14/202408:00BWPulse Biosciences Announces Positive 60-Day Follow-Up..
1/31/202408:00BWPulse Biosciences Announces Preliminary Findings from its..
1/09/202409:20EDGAR2Form 8-K - Current report
1/02/202409:20EDGAR2Form 8-K - Current report
1/02/202408:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
12/22/202309:08EDGAR2Form 8-K - Current report
12/20/202309:06EDGAR2Form 8-K - Current report
12/20/202308:00BWPulse Biosciences Announces First-in-Human Procedures with..
11/27/202317:29EDGAR2Form DEF 14A - Other definitive proxy statements
11/27/202309:08EDGAR2Form 8-K - Current report
11/21/202309:03EDGAR2Form 8-K - Current report
11/21/202308:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
11/17/202309:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202309:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202316:05BWPulse Biosciences to Present at the 35th Annual Piper..
11/13/202317:21EDGAR2Form PRE 14A - Other preliminary proxy statements
11/13/202317:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202309:12EDGAR2Form 8-K - Current report
11/13/202308:00BWPulse Biosciences Reports Business Updates and Third Quarter..
11/10/202316:56BWUPDATE Pulse Biosciences Announces New Time for Third..
11/03/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202316:05BWPulse Biosciences Schedules Third Quarter 2023 Financial..
10/24/202308:00BWPulse Biosciences Appoints Dr. Niv Ad as Chief Science..
10/02/202308:00BWPulse Biosciences Announces Collaboration with CardioNXT for..
9/29/202308:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
9/27/202308:00BWPulse Biosciences’ First Study in a Surgical Application of..
9/12/202309:15EDGAR2Form 8-K - Current report
9/07/202316:05BWPulse Biosciences to Present at Gilmartin Group Emerging..
8/31/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/24/202316:05BWPulse Biosciences Clarifies Details of Recent S-3 Filing
8/11/202316:49EDGAR2Form S-3 - Registration statement under Securities Act of..
8/10/202316:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:14EDGAR2Form 8-K - Current report
8/10/202316:05BWPulse Biosciences Reports Business Updates and Second..
7/27/202316:05BWPulse Biosciences Schedules Second Quarter 2023 Financial..
7/20/202309:25EDGAR2Form 8-K - Current report
7/14/202320:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/14/202320:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/18/202307:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
5/11/202316:05BWPulse Biosciences Reports Business Updates and First Quarter..
5/10/202309:29BWPulse Biosciences, Inc. Announces Planned Redemption of..
5/03/202308:00BWPulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief..
5/01/202308:00BWPulse Biosciences Announces $65 Million Private Placement

Your Recent History

Delayed Upgrade Clock